Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: Combination of Irreversible Electroporation and NK Immunotherapy for Recurrent Liver Cancer [Phase 1, Phase 2]
A combined Irreversible Electroporation and NK immunotherapy trial for recurrent liver carcinoma has completed Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2019-09-10Clinical Trial Update: TACE Using Doxorubicin-eluting Beads for Patients With HCC and Marginal Hepatic Reserve [NA]
Clinical trial update on doxorubicin-eluting bead chemoembolization for hepatocellular carcinoma with marginal hepatic reserve; study termin…
-
CLINICAL_TRIALS trial_result · 2019-09-10Clinical Trial Update: Preventive Effect of Celecoxib on Sorafenib-related Hand Foot Syndrome, a Single Center, Randomized Controlled Clinical Trail [Phase 4]
A phase 4 randomized trial evaluating whether celecoxib prevents hand-foot syndrome caused by sorafenib in hepatocellular carcinoma patients…
-
CLINICAL_TRIALS trial_result · 2019-09-06Clinical Trial Update: Ph 3 ADI-PEG 20 Versus Placebo in Subjects With Advanced Hepatocellular Carcinoma Who Have Failed Prior Systemic Therapy [Phase 3]
Phase 3 trial update comparing ADI-PEG 20 to placebo in advanced hepatocellular carcinoma after prior systemic therapy has completed.
-
CLINICAL_TRIALS trial_result · 2019-09-04Clinical Trial Update: A Phase 2 Study of Brivanib in Chinese Patients With Previously Treated Advanced HCC [Phase 2]
A Phase 2 trial evaluating brivanib in Chinese patients with previously treated advanced hepatocellular carcinoma has been completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-09-04Clinical Trial Update: Neoadjuvant Radiotherapy for HCC Involving Type I PVTT [Phase 2, Phase 3]
A Phase 2/3 trial update on neoadjuvant radiotherapy for hepatocellular carcinoma involving Type I portal vein tumor thrombus (PVTT).
-
CLINICAL_TRIALS trial_result · 2019-09-04Clinical Trial Update: A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol (S-HCC) [Phase 4]
Phase 4 trial update for EVL/GVS alone versus EVL/GVS with propranolol in gastroesophageal variceal hemorrhage and hepatocellular carcinoma;…
-
CLINICAL_TRIALS trial_result · 2019-08-30Clinical Trial Update: Primary Prevention of Patients With Hepatocellular Carcinoma and Concomitant Esophageal Varices [Phase 4]
Phase 4 trial update for primary prevention in patients with hepatocellular carcinoma and concomitant esophageal varices.
-
CLINICAL_TRIALS trial_result · 2019-08-30Clinical Trial Update: Open Label Trial of Immunotherapy for Advanced Liver Cancer [Phase 2]
Open-label Phase 2 trial update of an immunotherapy for advanced liver cancer, with conditions including hepatocellular carcinoma and liver …
-
CLINICAL_TRIALS trial_result · 2019-08-26Clinical Trial Update: TACE Combined With Anlotinib Treatment of Middle-advanced Hepatocellular Carcinoma (HCC) Patients [Phase 2]
Phase 2 trial update on combining transarterial chemoembolization (TACE) with anlotinib for middle-advanced hepatocellular carcinoma (HCC).
-
CLINICAL_TRIALS trial_result · 2019-08-22Clinical Trial Update: The Effect of Urea Cream on Sorafenib-associated Hand-Foot Skin Reaction [Phase 4]
Phase 4 trial evaluating whether urea cream reduces hand-foot skin reaction caused by sorafenib in hepatocellular carcinoma patients; study …
-
CLINICAL_TRIALS trial_result · 2019-08-20Clinical Trial Update: TACE With Lenvatinib Versus Lenvatinib Alone in in First-line Treatment of Advanced HCC [Phase 3]
Phase 3 trial comparing transarterial chemoembolization (TACE) with lenvatinib versus lenvatinib alone in first-line treatment of advanced h…
-
CLINICAL_TRIALS trial_result · 2019-08-20Clinical Trial Update: Remote Ischemic Conditioning (RIC) in Recipients of Brain Death Donor Livers - A Feasibility and Safety Study [NA]
A completed feasibility and safety study evaluating remote ischemic conditioning in recipients of brain death donor livers; results posted i…
-
CLINICAL_TRIALS trial_result · 2019-08-19Clinical Trial Update: Anti-PD-1therapy Combined With Thermal Ablation for Advanced HCC [Phase 2]
Phase 2 trial evaluating anti-PD-1 therapy in combination with thermal ablation for advanced hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2019-08-13Clinical Trial Update: The Impact on Recurrence Risk of Adjuvant Lenvatinib for Patients With Hepatocellular Carcinoma And Microvascular Invasion (MVI) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial. [Phase 3]
Phase 3 randomized trial assessing whether adjuvant lenvatinib reduces recurrence risk after hepatectomy in hepatocellular carcinoma with mi…
-
CLINICAL_TRIALS trial_result · 2019-08-13Clinical Trial Update: The Efficacy of Transarterial Chemoinfusion (TAI) Combine Lenvatinib in Advanced Hepatocellular Carcinoma (HCC) [Phase 3]
Phase 3 trial evaluating transarterial chemoinfusion (TAI) combined with lenvatinib in advanced hepatocellular carcinoma is reported as ongo…
-
CLINICAL_TRIALS trial_result · 2019-08-09Clinical Trial Update: Anlotinib Hydrochloride Combined With Sintilimab Injection in the Treatment of Advanced Hepatocellular Carcinoma (HCC) [Phase 2]
Phase 2 clinical trial evaluating anlotinib hydrochloride combined with sintilimab for advanced hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2019-08-09Clinical Trial Update: c-Met Second-Line Hepatocellular Carcinoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial update for a c-Met targeted approach in second-line hepatocellular carcinoma has completed enrollment with result…
-
CLINICAL_TRIALS trial_result · 2019-08-08Clinical Trial Update: DCE-MRI Using Dotarem® in Evaluation of Therapeutic Response to Sorafenib in Patients With Advanced Stage HCC [Phase 4]
Phase 4 trial evaluating DCE-MRI with Dotarem® to assess therapeutic response to sorafenib in advanced hepatocellular carcinoma; study termi…
-
CLINICAL_TRIALS trial_result · 2019-08-07Clinical Trial Update: Orantinib In Combination With Transcatheter Arterial Chemoembolization In Patients With Unresectable Hepatocellular Carcinoma [Phase 3]
Phase 3 trial of Orantinib with transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma was terminated; results po…
-
CLINICAL_TRIALS trial_result · 2019-08-05Clinical Trial Update: Clinical Study of Antiviral and Aspirin Treatment in Liver Cancer After Radical Surgery [Phase 3]
Phase 3 trial evaluating antiviral and aspirin therapy following radical surgery for hepatocellular carcinoma with recurrence.
-
CLINICAL_TRIALS trial_result · 2019-07-30Clinical Trial Update: SGI-110 in the Treatment of Advanced Hepatocellular Carcinoma (HCC) [Phase 2]
Phase 2 study of SGI-110 (guadecitabine) in advanced hepatocellular carcinoma was completed and its results were posted on 2019-07-30.
-
CLINICAL_TRIALS trial_result · 2019-07-29Clinical Trial Update: Combination Camrelizumab (SHR-1210) and Apatinib for Downstaging/Bridging of HCC Before Liver Transplant [Phase 1, Phase 2]
Phase 1/2 trial exploring a combination of Camrelizumab and Apatinib for downstaging bridging to liver transplant in hepatocellular carcinom…
-
CLINICAL_TRIALS trial_result · 2019-07-24Clinical Trial Update: Efficacy, Safety, and Pharmacokinetic of MSC2156119J in Asian Participants With Hepatocellular Carcinoma [Phase 1, Phase 2]
Phase 1/2 trial assessing efficacy, safety, and pharmacokinetics of MSC2156119J in Asian participants with hepatocellular carcinoma complete…
-
CLINICAL_TRIALS trial_result · 2019-07-11Clinical Trial Update: SHR-1210 Plus Apatinib in Patients With Advanced-Stage Hepatocellular Carcinoma [Phase 2]
Phase 2 trial evaluating SHR-1210 plus apatinib in advanced hepatocellular carcinoma is reported, with status currently unknown.